A068760 logo

Celltrion Pharm, Inc. Stock Price

KOSDAQ:A068760 Community·₩2.4t Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A068760 Share Price Performance

₩54,500.00
5970.59 (12.30%)
₩54,500.00
5970.59 (12.30%)
Price ₩54,500.00

A068760 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Minimal risk with weak fundamentals.

1 Risk
0 Rewards

Celltrion Pharm, Inc. Key Details

₩274.7b

Revenue

₩193.9b

Cost of Revenue

₩80.8b

Gross Profit

₩54.8b

Other Expenses

₩26.0b

Earnings

Last Reported Earnings
Mar 31, 2021
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About A068760

Founded
1976
Employees
n/a
CEO
Yoo Young-Ho
WebsiteView website
www.celltrionph.com

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea. Celltrion Pharm, Inc. (KOSDAQ:A068760) operates as a subsidiary of Celltrion, Inc.

Recent A068760 News & Updates

Recent updates

No updates